BioInvent International AB's total assets for Q1 2025 were kr862.79M, a decrease of -12.78% from the previous quarter. SE:BINV total liabilities were kr93.07M for the fiscal quarter, a -10.01% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.